An unknown buyer entered into an agreement to acquire Manufacturing facility in Modiin, Israel and certain related assets from Vascular Biogenics Ltd. (NasdaqGM:VBLT) for $7.1 million on February 15, 2023. The asset sale is subject to customary closing conditions as provided in the purchase agreement and expected to close on or about March 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6188 USD | -11.13% |
|
-18.58% | -67.26% |
06-24 | Notable Labs, Ltd.(NasdaqCM:NTBL) added to S&P TMI Index | CI |
05-16 | Chardan Cuts Price Target on Notable Labs to $5 From $7 on Higher Expected Share Count Dilution, Keeps Buy Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.26% | 5.58M | |
+16.45% | 122B | |
+21.96% | 116B | |
+24.08% | 27.03B | |
-20.05% | 20.36B | |
-16.40% | 16.43B | |
-16.28% | 15.91B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- NTBL Stock
- News Notable Labs, Ltd.
- An unknown buyer entered into an agreement to acquire Manufacturing facility in Modiin, Israel and certain related assets from Vascular Biogenics Ltd. for $7.1 million.